Pillstats
Rx only · Injection, Solution · Intramuscular

Lincomycin Hydrochloride

Brands: Lincomycin · Lincocin · Lincomycin Hydrochloride

5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
5 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6398
US makers5 labelers
Packages9
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5481.1K1.6K2.2K2025 Q12025 Q22025 Q32025 Q42026 Q1
796
Rx · 2026 Q1
1.4K
Units dispensed
-58%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it5 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Pharmacia & Upjohn Company LLCunknown2SUPPLYING
Sagent Pharmaceuticalsunknown2SUPPLYING
XGen Pharmaceuticals DJB, Inc.unknown2SUPPLYING
Gland Pharma Limitedunknown2SUPPLYING
Henry Schein Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 26, 2026
    RESOLVEDShortage resolved: Lincomycin Hydrochloride Injection (XGen Pharmaceuticals DJB, Inc.)

    Lincomycin Hydrochloride Injection — reported in shortage by XGen Pharmaceuticals DJB, Inc.. Therapeutic category: Anti-Infective.

  • Mar 26, 2026
    SHORTAGEDrug shortage: Lincomycin Hydrochloride Injection (XGen Pharmaceuticals DJB, Inc.)

    Lincomycin Hydrochloride Injection — reported in shortage by XGen Pharmaceuticals DJB, Inc.. Therapeutic category: Anti-Infective.

  • Feb 25, 2026
    RESOLVEDShortage resolved: Lincomycin Hydrochloride Injection (Pfizer Inc.)

    Lincomycin Hydrochloride Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Anti-Infective.

  • Feb 25, 2026
    SHORTAGEDrug shortage: Lincomycin Hydrochloride Injection (Pfizer Inc.)

    Lincomycin Hydrochloride Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Anti-Infective.